Abstract
hygienic; individualized dialysis fluid; quality of treat-35 days (range 2-362 days). ment; survival The demographic data for the patients are presented in patients has increased. Currently approximately 27% (n= Table 1 . Demographic data of the patient group a week, this is reevaluated weekly by the doctor in charge.
In order to achieve a good clinical result, i.e. pre-dialysis BP <140/90 mmHg, minimal medication and diminished determined by the doctor in charge.
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The dialysate composition is selected according to laborat- and 30 mmol/l ascorbic acid. Acetic acid or acetate is never used. This procedure leads to a highly individualized composition for the dialysis fluid; currently we have 72 different 33) of our patients are diabetic, of which 80% suffer from prescriptions for 120 patients. For every patient an individual Type II diabetes mellitus. maximum ultrafiltration rate is defined empirically, Albumin status, protein catabolic rate (PCR), Kt/V and depending on clinical conditions such as heart insufficiency additional medication were examined in population sub-or diabetes mellitus. The range of maximal ultrafiltration is groups because of a lack of information for the whole period. 500-1000 ml/h. Effective treatment time is determined by The demographic data for these subgroups are presented in blood flow and individual maximum ultrafiltration rate. For Table 2 . All patients examined for the described parameters example, 60 l dialysis fluid with the standard blood and during the observation period were included. All parameters dialysis fluid flow of 250 ml/min requires a treatment time were measured following a 2-day dialysis-free interval.
of 4 h. With an individual maximum ultrafiltration rate of 500 ml/h, a total of 2000 ml of ultrafiltration can be removed during 4 h. Treatment time is individually prolonged by
Treatment modalities
lowering the blood flow if the weight gain of the patient exceeds the individual upper ultrafiltration limit. In 1995 the Every patient received a specific dose of dialysis fluid, mean prolongation of treatment time was 0.5 h, but the depending on individual residual function and dry weight.
average prolongation for all patients was 3 min. In 1995 Figure 1 shows the data for the patients in 1995. We usually the average weight of the patients was 67.9±14.4 kg (range: start treatment with a dose of 60 l dialysis fluid three times 38-112 kg), the mean treatment time was 4.2±0.65 h. From 1971 to 1989 most of the treatments were performed using CuprophanA membranes. Based on the good hygienic quality of our dialysis fluid, backfiltration has not been regarded as a risk since 1992. We therefore use a polysulfon membrane (Fresenius F 60A) as a standard dialyser to take advantage of the known benefits of a high-flux membrane. In addition, the capacity of the polysulfon membrane to adsorb cytokine-inducing materials fits our hygienic concept [4, 5] . Anticoagulation is achieved with heparin or fragmin, administered as a single injection before the start of treatment. Additional drug treatment consisted of oral phosphate binders (mainly aluminumhydroxyd and calciumcarbonat) and ferrum-III-oxidum saccharatum which was added intravenously to achieve a ferritin level of between 40 and 150 ng/ml. Erythropoietin was administered once a week subcutaneously if a haemoglobin level of between 9.5 and dialysis machine. The filling and emptying process is com-10.5 mg/dl was not achieved spontaneously, and when other pletely automated. An UV radiator with an emission at reasons apart from dialysis anaemia (renal anaemia+dialysis 254 nm is used for disinfection. The following points are depending blood loss) were excluded. The dose of erythropo-adhered in order to maintain a hygienic system. ietin is indicated as an index in units/kg body weight/week.
$
The vessel consists of smooth glass without corners. For this study we estimated the haemoglobin level and the $ There are no valves or sensors in the fluid path. index as the mean value over 3 months. Antihypertensive $ The tank is filled with ultrapure water taken from a drugs were added if the pre-dialysis blood pressure remained special water buffering system. constantly above 140/90 mmHg although the dry weight was $ The tank is never opened except for a very small opening obtained. Other drugs, such as insulin, were prescribed for in-and outflow. depending on underlying diseases. Blood chemistry values $ Filling, emptying and disinfection occurs under strong were determined every month, parathyroid hormone data UV radiation. once a year and other tests as indicated. The Kt/V index $ Specially designed connectors are used instead of the and PCR are not determined routinely at our center. However, we determined these data retrospectively. Kt/V Hansen connector. was computed for patients without residual renal function $ The dialysis fluid is prepared mostly from dry concenusing pre-and post-dialysis urea with the corrected formula trates to avoid the contamination problems of liquid of Daugirdas [6 ] . PRC was estimated from beginning of the bicarbonate concentrate. week pre-and post dialysis urea concentrations using the Owing to the hygienic concept, the system operates with equations developed by Daugirdas and Depner [7] .
an almost sterile and pyrogen-free (<6 pg/ml lipopolysacchaPatients serum albumin levels were obtained by turbidimride) dialysis fluid [10, 12, 13] . During treatment, fresh dialysis etric measurements (Behring Werke, Germany).
fluid is taken from the top of the system and the used dialysis fluid is returned to the bottom. There is a sharp interface
The GENIUS system between the used and fresh dialysis fluids because of their different physical qualities. As the tank is closed, always This system was developed by the late B. Tersteegen completely filled and without compliance, true volumetric . Based on the principles formulated by Claude ultrafiltration control is simply achieved by controlling the Bernard [8] and Homer W. Smith [9] , it was originally outflow from the dialysis fluid tank. A double-sided roller named milieu interior regulator.
pump drives both blood and dialysis fluid flows with a ratio Technical details of the system are described in [10] [11] [12] .
The principle design is shown in Figure 2 . For each treatment, fresh dialysis fluid is prepared according to the physician's prescription by mixing mostly dry ingredients with preheated ultrapure water. The total amount of dialysis fluid is Statistical analysis put into the thermally insulated glass tank (V=75 l ) of the Patient characteristics are described by frequency tables or means±SD and range. Age at start of dialysis was categorized into five classes (0-34, 35-44, 45-54, 55-64, 65+ years). The survival time for each patient represents the period from the first dialysis session until death. If the patient received a kidney transplant or survived until the end of the study or at least 30 days after leaving our centre his survival time is called censored [14] . Thus, the censoring events were transplantation, change of dialysis center or end of data collection for this study. The corresponding censored survival time is the period from the first dialysis session until the (first) censoring event. Transplantation was considered as a censoring event, and possible further time of dialysis after transplantation was not added because transplantation is a (time-dependent) risk factor for death. Deaths were followed up for 30 days after the patient's last dialysis treatment in our center.
Some patients started dialysis in other centres. Therefore, inclusion criteria for the survival analysis was a maximum period of 1 year of dialysis outside our centre before being treated in our outpatient clinic. In concordance, the starting point of survival time was the date of first dialysis. Thus, the survival data can be interpreted as patient outcome treated with the specific method of dialysis in our centre. Including all patients without this restriction into the analysis would have led to a biased estimate of the survival probabilities with higher survival rates.
Survival probabilities depending on duration since first dialysis were estimated by the Kaplan-Meier method [14] . The overall survival probabilities were plotted with approx- dependent survival probabilities were observed among In each year from 1983 to 1995, the mean number of days age classes and different aetiologies. There were no in hospital per patient was calculated. This was only a crude significant differences between males and females (P= estimate, because less than half of the patients were in the 0.07). After fitting a multiple Cox regression model, hospital per year. In addition, the percentage of hospitalized age and IDDM turned out to be the only significant patients per year and the median and range of the number risk factors. This result was the same for stepwise and of hospital days per year per hospitalized patient were backward variable selection procedures. the results of the Cox regression models in detail,
The cumulative incidence of carpal tunnel syndrome (CTS ) before and after variable selection. Higher age significwas estimated depending on duration of dialysis using the Kaplan-Meier method [14] . Only CTS with surgery were antly increased the risk of death (P<0.01). The risk considered. The 'event' time for each patient was the duration of death for IDDM patients was estimated to be about of time from the first dialysis until surgery of the first CTS, three-fold higher than for non-IDDM patients or until CTS-censoring by death, (first) transplantation or (P<0.01). The age factor dominated the effect of last dialysis date in our center. Thus, CTS-censoring events NIDDM.
were death, (first) transplantation or last dialysis date in Figure 4 shows the survival curve with approximatour center.
ive pointwise 95% CI for all patients aged 35-44 years. All statistical calculations were carried out using the SAS The differences in survival probability between diabetic software package (version 6.11, SAS Institute, Cary, NY ).
and non-diabetic patients increased continuously with dialysis duration ( Figure 5 ).
The incidence of cardiovascular death was higher
Results
than for the other specific causes of death ( Table 4) . Survival Hospitalization During the study period, 144 (36%) of the 399 patients died before transplantation, 68 (17%) received trans-Reasons for hospitalization are presented in Table 5 . Table 6 shows percentages of hospitalized patients and plants, 89 (22%) left our center, and 98 (25%) were still receiving dialysis in our center on April 1996. median and range of cumulative days in hospital per hospitalized patient per year from 1983 to 1995. The Figure 3 shows the estimated overall survival probabilities together with approximative pointwise 95% mean number of hospital days for all patients per year was lower because patients without a hospital visit confidence intervals (CI ). The shape of the estimated survival probability was approximately linear from counted as 0 days. start of the study up to 10 years duration of dialysis. aValues of all variables except age: 0=no/1=yes. Fig. 3 . Kaplan-Meier survival curve with 95% CI, n=399, 144 died.
Overall P-value <0.01. 
Additional observations
Serum albumin levels were measured in 1991 and 1995. Erythropoietin (1991) was administered in 41 patients (39%) in order to exclusively treat dialysis The mean serum albumin level was 4.3 g/dl. Eightytwo per cent of our patients had serum albumin levels anaemia. Haemoglobin level was 98±8 g/l (mean± SD, 3 months observation) with an erythropoietin >4.0 g/dl (Figure 6 ). The normalized PRC values were 1.10±0.22 g/kg/day. consumption of 37±28 units/kg bw/week. In 15 probabilities from our data and compare them with other studies ( Tables 7 and 8 ). The survival rates in patients (14%) additional reasons for anaemia were Tassin were higher than ours (Dü sseldorf ), whereas diagnosed (e.g. gastrointestinal bleeding). These the EDTA, Seattle and Philadelphia estimates were patients were not investigated.
lower. It is our opinion that good survival rates result In 65% of our patients an acceptable blood pressure from several cumulative factors. Firstly, hypertension (pre-dialytic value <140/90 mmHg) was achieved is judged to be a major risk factor for survival [3, 17] . without any additional antihypertensive drugs.
In the Tassin group, excellent survival data are achieved Only eight CTS with surgery were observed. by strong blood pressure control; 97% of the patients Figure 7a shows the cumulative incidences of CTS were normotensive without additional antihypertensdepending on the duration of dialysis. The first CTS ives. In our study, 65% of the patients did not need occurred 4.8 years after beginning dialysis. The cumu-antihypertensive drugs. This is clearly in contrast to lative incidence of CTS after 10 years of dialysis was European [18] and US [19] statistics where only 18 estimated as 7% (95% CI: 0-14%), after 13 years 15% and 18.4% of patients respectively, do not need antihy-(95% CI: 0-31%). The estimation is not precise because pertensives. These data are more notable as our average there were only 18 cases after 10 years of CTS-treatment time (1995: 4.2±0.65 h) in the scope of free dialysis.
European practice is much shorter than the well-known The Kt/V data for 132 patients without residual Tassin long-time treatments of about 8 h. renal function was 1.21±0.17 (mean±SD).
Secondly, the good albumin status of our patients played a role. The work of Lowrie and Lew [20] has shown that serum albumin level is a very sensitive Discussion marker for risk of death. The relative risk of death at a level serum albumin of 2.5-3.0 g/dl is 15-fold higher than at the reference value of 4.0-4.5 g/dl. Serum Survival is the ultimate measurement of the success of renal replacement therapy. When discussing survival albumin is a much more sensitive marker than urea where an increase in the risk of death by a factor of of international standards for water and dialysate purity by a factor of at least 10 has to be called for more than 2.3 has not been found. Figure 6 shows that in our population (1991, 1995; see Table 2 ) more than [22] . Such a high standard is fulfilled by this system without the requirement for extra filters and extra cost. 82% of the patients had serum albumin levels of 4.0 g/dl or more. This is far better than results reported Berland et al.
[27] studied the connection of pyrogen content of dialysis fluid and occurrence of CTS by Lowrie and Lew [20] where only 33% of the patients reached these values. We offer the hypothesis that this ( Figure 7b ). The cumulative CTS incidence in our study correspond to these results (Figure 7a ). is a result of the ultrapure dialysis fluid and the lower degree of induced disturbance in the patients' anabolAs expected, diabetic patients have a low survival rate ( Figure 5 ). This corresponds to the results of the ism. This hypothesis is supported by the work of Kaysen [21] who states that albumin synthesis in the Cox regression analysis. Age and IDDM were the only significant risk factors of mortality. There was no liver is actively suppressed by inflammation. The response to inflammation is mediated by lymphokines, significant effect of any other etiology of renal failure in our data ( Table 3 ). In particular, the risk of NIDDM TNF, IL-1, and IL-6. Since Lonnemann et al. [22] pointed out that pyrogenic bacterial products induce was dominated by the risk of age. Two reasons could possibly explain this result. First, the subgroup of the production of these proinflammatory cytokines, a correlation between ultrapure dialysis fluid and high NIDDM patients consisted only of 19 patients.
Furthermore, the diagnosis of NIDDM as etiology serum albumin levels seems reasonable.
Finally, the very low amount of bacterial and pyro-factor of renal failure could not always be clearly differentiated against other factors. Thus, the effect of gene contamination of the dialysate is thought to be the reason for the low incidence of death by infection NIDDM could be distorted due to this problem of misclassification. ( Table 4) .
Another feature of our therapy is the strictly individualized composition of the dialysis fluid. The tech-
Conclusion
nical concept of GENIUS makes it possible in daily practice to deliver this without additional work, cost or storage space. Over recent years, the therapeutic We conclude that an adequate, high quality dialysis importance of the dialysate composition has gained therapy can be obtained with the GENIUS batch type more and more attention. Ronco et al. [23] stated: dialysis system. Its technical design, derived from prin-'The composition of dialysis fluid represents today one ciples of physiology and therapeutic requirements, has of the most critical aspects in the personalized treat-proved practical in day-to-day use. Our results suggest ment of end stage renal disease. Dialysis fluid must be therapeutic benefits from our method of treatment considered as a drug and therefore it must be prescribed using ultrapure water and individually composed diaboth in quantity and quality adequate to fulfill the lysis fluid. Nevertheless, solid conclusions cannot be patients clinical requirement'.
drawn from this kind of centre-based retrospective It is remarkable that the excellent survival rates in follow-up study. This would be possible only by a Tassin are reached with a standard dialysate composi-controlled clinical trial with randomized treatment tion without adaptation to the single patient. This groups. seeming contradiction to our approach is explained by the hypothesis that the importance of fluid composition Acknowledgements. We thank Mr Hans Lagendijk for his many years of careful laboratory work in our centre. In memoriam Bernd is greater, the shorter the duration of dialysis. With The need for erythropoietin is comparable with other
